BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Si W, Li Y, Han Y, Zhang F, Wang Y, Linghu RX, Zhang X, Yang J. Epidemiological and Clinicopathological Trends of Breast Cancer in Chinese Patients During 1993 to 2013: A Retrospective Study. Medicine (Baltimore). 2015;94:e820. [PMID: 26131834 DOI: 10.1097/md.0000000000000820] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Majid RA, Hassan HA, Muhealdeen DN, Mohammed HA, Hughson MD. Breast cancer in Iraq is associated with a unimodally distributed predominance of luminal type B over luminal type A surrogates from young to old age. BMC Womens Health 2017;17:27. [PMID: 28388952 DOI: 10.1186/s12905-017-0376-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
2 Bao X, Sun K, Tian X, Yin Q, Jin M, Yu N, Jiang H, Zhang J, Hu Y. Present and changing trends in surgical modalities and neoadjuvant chemotherapy administration for female breast cancer in Beijing, China: A 10-year (2006-2015) retrospective hospitalization summary report-based study. Thorac Cancer 2018;9:707-17. [PMID: 29624915 DOI: 10.1111/1759-7714.12636] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Huang A, Zhu L, Tan Y, Liu J, Xiang J, Zhu Q, Bao L. Evaluation of automated breast volume scanner for breast conservation surgery in ductal carcinoma in situ. Oncol Lett 2016;12:2481-4. [PMID: 27698816 DOI: 10.3892/ol.2016.4924] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Iwata H, Im SA, Masuda N, Im YH, Inoue K, Rai Y, Nakamura R, Kim JH, Hoffman JT, Zhang K, Giorgetti C, Iyer S, Schnell PT, Bartlett CH, Ro J. PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Therapy-Safety and Efficacy in Asian Patients. J Glob Oncol. 2017;3:289-303. [PMID: 28831437 DOI: 10.1200/jgo.2016.008318] [Cited by in Crossref: 51] [Cited by in F6Publishing: 26] [Article Influence: 12.8] [Reference Citation Analysis]
5 Lan G, Li J, Wen Q, Lin L, Chen L, Chen L, Chen X. Cytotoxic T lymphocyte associated antigen 4 expression predicts poor prognosis in luminal B HER2-negative breast cancer. Oncol Lett 2018;15:5093-7. [PMID: 29552143 DOI: 10.3892/ol.2018.7991] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
6 Wei H, Wang M, Ou J, Jiang W, Tian F, Sheng Y, Li H, Xu H, Zhang R, Guan A, Wang C, Jiang H, Ren Y, He J, Liu J, Huang W, Liao N, Cai X, Ming J, Ling R, Xu Y, Hu C, Zhang J, Guo B, Ouyang L, Shuai P, Liu Z, Zhong L, Jing R, Zeng Z, Zhang M, Zhang T, Xuan Z, Tan X, Liang J, Pan Q, Chen L, Zhang F, Fan L, Zhang Y, Yang X, Li J, Chen C, Jiang J. Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations. Oncol Lett 2018;15:9420-8. [PMID: 29805665 DOI: 10.3892/ol.2018.8538] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Lei YY, Bai S, Chen QQ, Luo XJ, Li DM. Clinical and pathological features and risk factors for primary breast cancer patients. World J Clin Cases 2021;9:5046-53. [PMID: 34307555 DOI: 10.12998/wjcc.v9.i19.5046] [Reference Citation Analysis]
8 Rocha-Brischiliari SC, Oliveira RR, Andrade L, Brischiliari A, Gravena AA, Carvalho MD, Pelloso SM. The Rise in Mortality from Breast Cancer in Young Women: Trend Analysis in Brazil. PLoS One 2017;12:e0168950. [PMID: 28046087 DOI: 10.1371/journal.pone.0168950] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
9 Estiar MA, Esmaeili R, Zare AA, Farahmand L, Fazilaty H, Zekri A, Jafarbeik-Iravani N, Majidzadeh-A K. High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer. Clin Exp Med 2017;17:547-53. [PMID: 27909883 DOI: 10.1007/s10238-016-0442-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
10 Shi Y, Yu Y, Wang Z, Wang H, Bieerkehazhi S, Zhao Y, Suzuk L, Zhang H. Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells. Oncotarget 2016;7:73697-710. [PMID: 27655642 DOI: 10.18632/oncotarget.12048] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
11 Balekouzou A, Yin P, Pamatika CM, Bishwajit G, Nambei SW, Djeintote M, Ouansaba BE, Shu C, Yin M, Fu Z, Qing T, Yan M, Chen Y, Li H, Xu Z, Koffi B. Epidemiology of breast cancer: retrospective study in the Central African Republic. BMC Public Health 2016;16:1230. [PMID: 27923361 DOI: 10.1186/s12889-016-3863-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]